BioGeneration Ventures (BGV), an early-stage VC in European biopharma, has closed BGV V at €150m (US$167m), its largest fund since launching its first in 2006. BGV V was said to…
BioGeneration Ventures (BGV), an early-stage VC in European biopharma, has closed BGV V at €150m (US$167m), its largest fund since launching its first in 2006. BGV V was said to…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference